Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON
  1. Homepagina
  2. Aandelen
  3. Zwitserland
  4. Swiss Exchange
  5. Roche Holding AG
  6. Nieuws
  7. Persberichten
    ROG   CH0012032048

ROCHE HOLDING AG

(ROG)
OverzichtKoersenGrafiekenNieuwsRatingenAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproducten 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuwsAnalyse MarketScreener
Communiquťs de presse de la sociťtť ROCHE HOLDING AG
20/09ROCHE : Booster programme welcome but plans must be in place for boosters for al..
AQ
20/09ROCHE : New Phase III Data Support the Benefit of Genentech's Tecentriq in Early..
BU
20/09ROCHE : New Phase III data support the benefit of Roche's Tecentriq in early-sta..
AQ
20/09ROCHE : Invitation to Roche's 3rd Quarter Sales 2021 Webinar
PU
17/09ROCHE : receives positive CHMP opinion for Gavretoģ (pralsetinib) for the treatm..
AQ
17/09ROCHE : presents first phase II data on giredestrant, a next generation selectiv..
PU
15/09ROCHE : opens access to pathology imaging tools to improve patient care
AQ
09/09ROCHE : signs definitive share purchase agreement with long-term partner TIB Mol..
AQ
07/09REMINDER : Invitation to Roche's Virtual Pharma Day - Tuesday, 14th September 20..
PU
07/09ROCHE : Adaptimmune Enters into a Strategic Collaboration with Genentech to Rese..
AQ
07/09ROCHE : to present data from industry leading portfolio at ESMO 2021 showing sig..
AQ
07/09GENENTECH : to Present Data From Industry-Leading Portfolio at ESMO 2021 Showing..
BU
30/08ROCHE : Partners with the Kolisi Foundation, One By One Target Covid Campaign an..
BU
30/08ROCHE : Genentech Provides Update on Tecentriq U.S. Indication for PD-L1-Positiv..
AQ
27/08GENENTECH : Provides Update on Tecentriq U.S. Indication for PD-L1-Positive, Met..
BU
27/08ROCHE : provides update on Tecentriq US indication for PD-L1-positive, metastati..
AQ
26/08ROCHE : Shlomo Zalman (Sam) Bregman, a Fox News Commentator, Prominent Rabbi, an..
AQ
24/08ROCHE : Shape Therapeutics enters into a strategic research collaboration with R..
AQ
23/08ROCHE : First monoclonal antibody treatment for COVID-19 approved for use in the..
AQ
19/08ROCHE : Joint Statement From Unitaid and the World Health Organization (On Behal..
AQ
18/08JOHNSON & JOHNSON : WHO urges J&J to stop shipping Covid vaccines from Africa to..
AQ
18/08ROCHE : receives FDA approval for first companion diagnostic to identify dMMR so..
AQ
09/08ROCHE : Phase III study shows Roche's Polivy plus R-CHP is the first regimen in ..
AQ
09/08ROCHE : Phase III Study Shows Genentech's Polivy Plus R-CHP Is the First Regimen..
BU
04/08ROCHE : FDA Grants Priority Review to Genentech's Tecentriq as Adjuvant Treatmen..
AQ
03/08ROCHE : US FDA grants Priority Review to Roche's Tecentriq as adjuvant treatment..
AQ
03/08ROCHE : FDA Grants Priority Review to Genentech's Tecentriq as Adjuvant Treatmen..
BU
02/08ROCHE : FDA expands authorized use of REGEN-COV (casirivimab and imdevimab)
PU
30/07ROCHE : Invitation to Roche's Virtual Pharma Day - Tuesday, 14th September 2021
PU
29/07PTC THERAPEUTICS : Significant Improvements in Survival and Developmental Milest..
AQ
29/07ROCHE : FDA accepts application for Roche's faricimab for the treatment of neova..
AQ
29/07ROCHE : FDA Accepts Application for Genentech's Faricimab for the Treatment of W..
BU
29/07ROCHE : Data for Roche's Evrysdiģ (risdiplam) published in New England Journal o..
AQ
28/07ROCHE : Data for Genentech's Evrysdi (risdiplam) Published in New England Journa..
BU
26/07ROCHE : Chugai Pharmaceutical Co., Ltd. - F. Hoffmann-La Roche Announces Half Ye..
AQ
22/07ROCHE : Half-year 2021 Investor Update
PU
22/07ROCHE : Half Year Report 2021
PU
22/07ROCHE : reports good half-year results - Investor Update
PU
22/07ROCHE : Half Year 2021 Presentation without appendix
PU
22/07ROCHE : Half Year 2021 Presentation with appendix
PU
22/07ROCHE : reports good half-year results
AQ
21/07ROCHE : FDA Grants Breakthrough Therapy Designation for Venclexta in Combination..
BU
20/07CHUGAI PHARMACEUTICAL : Antibody Cocktail, RONAPREVE for Intravenous Infusion Se..
AQ
20/07ROCHE : New data for Roche's Hemlibra reinforce safety profile in people with ha..
AQ
20/07ROCHE : Japan becomes first country to approve Ronapreve (casirivimab and imdevi..
AQ
19/07ROCHE : New Data for Genentech's Hemlibra (emicizumab-kxwh) Reinforce Safety Pro..
BU
19/07ROCHE : New data for Roche's Hemlibra reinforce safety profile in people with ha..
AQ
16/07REMINDER : Invitation to Roche's Half Year Results 2021 Presentation
PU
15/07CHUGAI PHARMACEUTICAL : Released Short Film Featuring Mayu Hotta and Nami Kishid..
AQ
12/07CHUGAI PHARMACEUTICAL : and Alebund Enter into Option and License Agreement for ..
AQ
09/07CHUGAI PHARMACEUTICAL : Disposal of Vaccines for Workplace Vaccination
AQ
09/07ROCHE : WHO guidelines now include Roche's diagnostic tests in expanded effort t..
AQ
08/07CHUGAI PHARMACEUTICAL : Files for Additional Indication of Tecentriq for the Adj..
AQ
02/07ROCHE : Media resources for Roche's 125 Years Anniversary
AQ
02/07ROCHE : to present new data at the ISTH 2021 Congress highlighting long-standing..
AQ
30/06ROCHE : Atea's AT-527, an oral antiviral drug candidate reduces viral replicatio..
PU
30/06SUPPORTING CANADA'S BACK TO NORMAL : Roche Diagnostics Canada introduces the new..
AQ
29/06CHUGAI PHARMACEUTICAL : Enspryng (Satralizumab) Approved by European Commission ..
AQ
28/06ROCHE : ENSPRYNG approved by European Commission as first and only at-home subcu..
AQ
25/06CHUGAI PHARMACEUTICAL : Genentech Announces FDA Emergency Use Authorization for ..
AQ
25/06ROCHE : FDA Accepts Application for Genentech's Port Delivery System With Ranibi..
AQ
25/06ROCHE : Invitation to Roche's Half Year Results 2021 Presentation
PU
25/06ROCHE : Actemra/RoActemra receives U.S. FDA Emergency Use Authorization for the ..
AQ
25/06GENENTECH : 's Actemra Receives FDA Emergency Use Authorization for the Treatmen..
BU
24/06PTC THERAPEUTICS : Evrysdi Approved in Japan for the Treatment of Spinal Muscula..
AQ
24/06ROCHE : Title test release to ensure the format looks goood
PU
24/06ROCHE : FDA accepts application for Roche's Port Delivery System with ranibizuma..
AQ
24/06ROCHE : FDA Accepts Application for Genentech's Port Delivery System With Ranibi..
BU
22/06Insulin pump Accessories Market Development, Outline, Competitive perspective..
AQ
17/06ROCHE : Check You Employment Agreement's Restrictive Covenant
AQ
16/06ROCHE : Atea Pharmaceuticals Announces Achievement of AT-527 Development Milesto..
AQ
15/06ROCHE : data at EAN 2021 showcase significant impact of therapies across diverse..
AQ
14/06CHUGAI PHARMACEUTICAL : Files New Drug Application in Japan for Faricimab, the F..
AQ
14/06PTC THERAPEUTICS : Pre-symptomatic Infants with Spinal Muscular Atrophy Achieved..
AQ
14/06ROCHE : announces data at EHA2021 reinforcing efficacy of Venclexta/Venclyxto co..
AQ
1  2  3  4  5  6  7  8  9  10Volgende
Volgende evenement op ROCHE HOLDING AG